Nooresh Mirani of AMSEC Research told CNBC-TV18, "Technically Biocon has given a major breakout above Rs 310 levels. Therefore, we expect the follow-on to continue towards Rs 360 to Rs 400. So, one can review the stock at Rs 360 to Rs 400 to book profit. So, it would be a hold at current levels."
The share touched its 52-week high Rs 321.50 and 52-week low Rs 240.00 on 16 November, 2012 and 30 July, 2012, respectively. Currently, it is trading 2.75 percent below its 52-week high and 30.27 percent above its 52-week low. Market capitalisation stands at Rs 6,253.00 crore. Also Read: Biocon plans Rs 1,200 capex over next 3 yrs: CitiDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
